Peritoneal carcinomatosis from advanced ovarian cancer:To treat or not to treat ethical issues suggested by a case study

Elena Colombetti, Mirco Nicoti, Maria Simonetta Spada, Marco Ceresoli, Luca Ansaloni, Gianmariano Marchesi, Luca Lorini, Davide Corbella, Federico Coccolini

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

Abstract

This article provides a brief description of an Epithelial Ovarian Cancer (EOC) case (stage Ⅳ) treated with the association of complete CytoReductive Surgery and Hypertermic IntraPEritoneal Chemotherapy (HIPEC). The use of HIPEC in EOC makes theoretic sense in view of the high rates of recurrence following standard treatment, but there are no randomized clinical trial to date and HIPEC for these patients still represents a radical treatment where the choice of no treatment may be acceptable since definitive cure is unlikely. We reviewed the entire decision making process considering the risk/benefit of the procedure in term of mortality/morbidity, the quality of life and the psychological profile of the patient 1 year after surgery. The platform World Health Organization- International Classification of Functioning, Disability and Health that permits evaluation of the person in relation to the psycho-social context is presented. A person-centred approach and assessment of health-related quality-of-life and disability in EOC survivors are of central importance for decision making.
Lingua originaleEnglish
pagine (da-a)14-20
Numero di pagine7
RivistaWORLD JOURNAL OF OBSTETRICS AND GYNECOLOGY
Stato di pubblicazionePubblicato - 2014

Keywords

  • Advanced epithelial ovarian cancer
  • Disability and Health
  • Ethical issues
  • Health related quality of life
  • Hyperthemic intraperitoneal chemotherapy
  • International Classification of Functioning

Fingerprint

Entra nei temi di ricerca di 'Peritoneal carcinomatosis from advanced ovarian cancer:To treat or not to treat ethical issues suggested by a case study'. Insieme formano una fingerprint unica.

Cita questo